✦ LIBER ✦

Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study

✍ Scribed by Katherine Y Look; Alan Sandler; John A Blessing; Joseph A Lucci III; Peter G Rose

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fixed-dose rate gemcitabine plus docetax

✍ Martee L. Hensley; John A. Blessing; Koen DeGeest; Ovadia Abulafia; Peter G. Ros 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Fixed-dose rate gemcitabine plus docetax

✍ Martee L. Hensley; John A. Blessing; Robert Mannel; Peter G. Rose 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Phase II study of oxaliplatin as second-

✍ Paula M. Fracasso; John A. Blessing; Kelly L. Molpus; Lisa M. Adler; Joel I. Sor 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 115 KB

A randomized phase III trial of gemcitab

✍ Hensley, M.L.; Miller, A.; O'Malley, D.M.; Mannel, R.S.; Behbakht, K.; Bakkum-Ga 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 110 KB

A phase II evaluation of flavopiridol as

✍ Edward C. Grendys Jr.; John A. Blessing; Robert Burger; James Hoffman 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Phase II Trial of Paclitaxel in Leiomyos

✍ Gregory Sutton; John A. Blessing; Harrison Ball 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 37 KB